[Federal Register Volume 78, Number 134 (Friday, July 12, 2013)]
[Notices]
[Page 41930]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-16738]
[[Page 41930]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60 Day-13-13ZJ]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-7570 or
send comments to Leroy Richardson, 1600 Clifton Road, MS-D74, Atlanta,
GA 30333 or send an email to [email protected].
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Generic Emergency Epidemic Investigation Data Collections--New--
Scientific Education and Professional Development Program Office
(SEPDPO), Office of Surveillance, Epidemiology, and Laboratory Services
(OSELS), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
CDC previously has conducted Emergency Epidemic Investigations
(EEIs) under Office of Management and Budget (OMB) control number 0920-
0008. CDC is seeking a new OMB generic clearance for a 3-year period to
collect vital information during EEIs in response to urgent outbreaks
or events (i.e., natural, biological, chemical, nuclear, radiological)
characterized by undetermined agents, undetermined sources,
undetermined transmission, or undetermined risk factors. These EEIs
represent a subset of those performed under OMB clearance 0920-0008.
Supporting effective emergency epidemic investigations is one of
the most important ways that CDC protects the health of the public. CDC
is frequently called upon to conduct EEIs at the request of local,
state, or international health authorities seeking support to respond
to urgent outbreaks or urgent public health-related events. In response
to external partner requests, CDC provides necessary epidemiologic
support to identify the agents, sources, modes of transmission, or risk
factors to effectively implement rapid prevention and control measures
to protect the public's health. Data collection is a critical component
of the epidemiologic support provided by CDC; data are analyzed to
determine the agents, sources, modes of transmission, or risk factors
so that effective prevention and control measures can be implemented.
During an unanticipated outbreak or event, immediate action by CDC is
necessary to minimize or prevent public harm. The legal justification
for EEIs are found in the Public Health Service Act (42 U.S.C. 301
[241] (a).
Successful investigations are dependent on rapid and flexible data
collection that evolves during the investigation and is customized to
the unique circumstances of each outbreak or event. Data collection
elements will be those necessary to identify the agents, sources, mode
of transmission, or risk factors. Examples of potential data collection
methods include telephone or face-to-face interview; email, web or
other type of electronic questionnaire; paper-and-pencil questionnaire;
focus groups; medical record review; laboratory record review;
collection of clinical samples; and environmental assessment.
Respondents will vary depending on the nature of the outbreak or event;
examples of potential respondents include health care professionals,
patients, laboratorians, consumers, and the general public.
Participation in EEIs is voluntary and there are no anticipated costs
to respondents other than their time. CDC will use the information
gathered during EEIs to rapidly identify and effectively implement
measures to minimize or prevent public harm.
CDC projects 60 EEIs in response to outbreaks or events
characterized by undetermined agents, undetermined sources,
undetermined transmission, or undetermined risk factors annually. The
projected average number of respondents is 200 per EEI, for a total of
12,000 respondents. CDC estimates the average burden per response is
0.5 hours and each respondent will be asked to respond once. Therefore,
the total estimated annual burden hours are 6,000. These estimates are
based on the reported burden for EEIs that have been performed during
the previous two years.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Avg. burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hrs.) (in hrs.)
----------------------------------------------------------------------------------------------------------------
Emergency Epidemic Emergency 12,000 1 0.5 6,000
Investigation Participants. Epidemic
Investigation
Data Collection
Instruments.
---------------------------------------------------------------------------------
Total..................... ................ .............. .............. .............. 6,000
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2013-16738 Filed 7-11-13; 8:45 am]
BILLING CODE 4163-18-P